Completed EUCTR 2008-002247-16
This study is completed in France, in the United Kingdom, in Belgium, .... It focuses on Schizophrenia.
In United Kingdom Schizophrenia Other
Countries France, United Kingdom, Belgium, ...
Sponsor Janssen-Cilag International N.V.
Condition Schizophrenia Completed NCT01714713
This study is completed in the United States, in Australia, in Canada, .... It is testing EVP-6124 (Alpha-7 nAChR) for schizophrenia.
In United Kingdom Schizophrenia Drug i A study involving a medication or substance. From 18 Years to 50 Years
Countries United States, Australia, Canada, ...
Sponsor FORUM Pharmaceuticals Inc
Condition Schizophrenia Completed EUCTR 2012-002785-12
This study is completed in the United Kingdom, in Sweden, in Italy, .... It is testing aripiprazole once-monthly versus paliperidone palmitate for schizophrenia.
In United Kingdom Schizophrenia Other
Countries United Kingdom, Sweden, Italy, ...
Sponsor H. Lundbeck A/S
Condition Schizophrenia Ongoing EUCTR 2018-003252-20
This study is ongoing in the United Kingdom, in Slovakia, in Poland, .... It is testing pimavanserin for depression.
In United Kingdom Depression Other
Countries United Kingdom, Slovakia, Poland, ...
Sponsor ACADIA Pharmaceuticals Inc
Condition Depression Completed EUCTR 2008-002699-83
This study is completed in France, in the United Kingdom, in Belgium, .... It is testing aripiprazole Intramuscular Depot for schizophrenia.
In United Kingdom Schizophrenia Other
Countries France, United Kingdom, Belgium, ...
Sponsor Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition Schizophrenia Completed EUCTR 2015-004835-10
This study is completed in the United Kingdom, in the Netherlands, in Germany, .... It is testing Transition to the Paliperidone Palmitate 3-Month Formulation for schizophrenia.
In United Kingdom Schizophrenia Other
Countries United Kingdom, Netherlands, Germany, ...
Sponsor Janssen-Cilag International NV
Condition Schizophrenia Ongoing EUCTR 2019-002213-19
This study is ongoing in the United Kingdom. It is testing efficacy of Lurasidone Adjunctive Therapy for Bipolarity.
In United Kingdom Bipolarity Other
Countries United Kingdom
Sponsor University of British Columbia
Condition Bipolarity Completed EUCTR 2013-001695-38
This study is completed in France, in the United Kingdom, in Belgium, .... It is testing LURASIDONE for schizophrenia.
In United Kingdom Schizophrenia Other
Countries France, United Kingdom, Belgium, ...
Sponsor SUNOVION PHARMACEUTICALS INC.
Condition Schizophrenia Suspended ISRCTN12138612
This summary needs review. Please check the official study record and contact the research team for details.
In United Kingdom Addiction Other Over 18 Years
Countries United Kingdom
Sponsor Coventry University
Condition Addiction Completed NCT04708262
This summary needs review. Please check the official study record and contact the research team for details.
In United Kingdom Suicidality Behavioral From 13 Years to 17 Years
Countries United Kingdom
Sponsor University of Manchester
Condition Suicidality Completed NCT06309277
This study is completed in the United Kingdom. It is testing of Single and Multiple Oral Doses of GM-1020 for Depression.
In United Kingdom Depression Drug From 18 Years to 65 Years
Countries United Kingdom
Sponsor Gilgamesh Pharmaceuticals
Condition Depression Completed NCT04038957
This study is completed in the United Kingdom. It focuses on schizophrenia.
Remote / online Schizophrenia Drug From 18 Years to 45 Years
Countries United Kingdom
Sponsor Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition Schizophrenia